Arca
Skip to content
Tools
Tools

Modus IR

System, X-Ray, Angiographic. 510(k) K231986, from Synaptive Medical, Inc. (Toronto, CA). Product code IZI, class 2.

As of Nov 18, 2026, K231986 is an FDA 510(k) held by Synaptive Medical, Inc., substantially equivalent on Mar 25, 2024 after 264 days, with no recalls tied to it in FDA's recall database.

  • Review time: 264 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

Modus IR used with the Synaptive Surgical Exoscope is indicated for fluorescence imaging in conjunction with indocyanine green to aid in the visualization of vessels (micro- and macro-vasculature) and blood flow in the cerebrovasculature before, during, and after neurosurgery, plastic, and reconstructive surgeries.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other IZI clearances

The newest 510(k)s for the same product code; their median review was 217 days; see every IZI device

Record

Type
Traditional
Received
Jul 5, 2023
Review panel
Radiology
Regulation
21 CFR 892.1600

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.